Medication info
Amozalatan XQ Tablets 5/50/5/10 mg

Amozalatan XQ Tablets 5/50/5/10 mg

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202007691 · Approved 2020.11.09 · Insurance code 643508340

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before using the amlodipine/losartan combination as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, the target blood pressure, and the expected likelihood of achieving the treatment goal with the combination compared with monotherapy. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years and older, a starting dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)

  • Essential hypertension
  • stage 2 hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to take Amlodipine/Losartan combination and Rosuvastatin/Ezetimibe combination at the same time. First, Amlodipine and Losartan are used for patients with essential hypertension where blood pressure control is difficult with monotherapy or as initial treatment for stage 2 hypertension. In addition, the Rosuvastatin and Ezetimibe combination helps to control cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. This medication is used in conjunction with dietary therapy, considering the causes of dyslipidemia or other diseases to help effectively control blood pressure and lipids. Thus, it is used safely and effectively for patients with both hypertension and dyslipidemia for managing blood pressure and cholesterol.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before using the amlodipine/losartan combination as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, the target blood pressure, and the expected likelihood of achieving the treatment goal with the combination compared with monotherapy. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years and older, a starting dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus and neonates if administered to pregnant women, so it must be discontinued immediately upon confirmation of pregnancy. In addition, when administered to patients with reduced blood volume, hypotension may occur with the first dose, so it should be treated in advance and monitored carefully. Patients with muscle-related disorders or impaired kidney function are at risk of muscle damage or renal failure while taking this medication, so they should consult a physician immediately if any symptoms arise. Patients with hypersensitivity to any component of this medication or certain conditions, such as severe liver function impairment or a history of angioedema, should not take this medication. Elderly patients, patients with very low blood pressure, and patients with hyperkalemia require closer monitoring when this medication is administered. This medication may affect the liver and kidneys, so it is important to regularly receive liver function tests and kidney function tests. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur, healthcare professionals must be notified immediately, and a muscle enzyme test may need to be conducted to check for abnormalities. This medication may interact with other medications, so it is essential to inform your doctor or pharmacist of any other medications being taken. Caution is required when driving or operating machinery as dizziness or drowsiness may occur. Additionally, since this medication contains lactose, patients with lactose intolerance should consult a physician before taking it.

Side effects

Craniosynostosis, anuria, hypotension, renal failure, elevated ALT, elevated AST, dermatitis, postural dizziness, syncope, rhabdomyolysis, pancreatic adenocarcinoma, facial swelling, unusual sensations, drug intolerance, colonic polyps, irritable bowel syndrome, esophagitis, dizziness, somnolence, neurodegenerative disorders, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infections, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated serum cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, orthostatic dizziness, generalized weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, sensory loss, dysesthesia, peripheral neuropathy, syncope, taste disturbance, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, increased sweating, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, vascular edema, vasculitis, anaphylactoid syndrome, abnormal liver function, intestinal vascular edema, fatigue, anemia, thrombocytopenia, myalgia, weakness, increased creatine kinase, elevated serum myoglobin, rhabdomyolysis, taste disturbance, dry cough, erythema multiforme, hyperkalemia, hyponatremia, elevated ALT, elevated AST, increased serum creatinine, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, renal failure, ventricular premature contractions, atrial fibrillation, hypoglycemia, weakness, hunger, diaphoresis, hand tremors, decreased concentration, spasms, altered consciousness, headache, dizziness, constipation, nausea, abdominal pain, pruritus, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, urticaria, rash, anaphylaxis, erythema multiforme, arthralgia, myalgia, elevated creatine phosphokinase, myopathy, rhabdomyolysis, increased hepatic aminotransferases, hepatitis, abdominal pain, nausea, pancreatitis, dysesthesia, depression, cholelithiasis, cholecystitis, fatigue, chest pain, chest discomfort, edema, myasthenia, generalized edema, headache, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, phlegm, rhinorrhea, limb pain, arthralgia, hypoglycemia, increased serum creatine phosphokinase, abnormal liver function tests, generalized pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture, and it is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. Storing it this way helps maintain the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.